![](/img/cover-not-exists.png)
Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy
Li, Xiaoying, Shao, Minhua, Wang, Shiming, Zhao, Xueying, Chen, Hongyan, Qian, Ji, Song, Xiao, Wang, Jiucun, Jin, Li, Wu, Junjie, Li, Qiang, Bai, Chunxue, Han, Baohui, Gao, Zhiqiang, Lu, DaruVolume:
35
Language:
english
Journal:
Tumor Biology
DOI:
10.1007/s13277-014-2427-6
Date:
November, 2014
File:
PDF, 774 KB
english, 2014